Commitments and Contingencies (Details Narrative) - USD ($)			12 Months Ended		36 Months Ended
	Oct. 07, 2014	Dec. 24, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015
Consulting and advisory fees			$ 52,625
Aggregate principal cash obligation and commitments amount			713,927		$ 713,927
Principal cash obligations and commitments included in current liabilities			124,050		124,050
ProActive Capital Resources Group LLC [Member]
Consulting and advisory fees	$ 1,500		13,500	$ 12,000
Dr Kathleen P Mullinix [Member]
Consulting and advisory fees			25,000	25,000
Annual cash compensation				25,000
BioPharmaWorks LLC [Member]
Consulting and advisory fees			10,000
Theradex Systems, Inc [Member]
Clinical costs charged to operations					$ 1,660,725
Theradex Systems, Inc [Member]
Clinical costs charged to operations			958,896	423,108
Theradex Systems, Inc [Member] | Phase 1 Clinical [Member]
Estimated total clinical costs to be charged to operations			$ 2,200,000
Percentage of clinical trial service			60.00%
Percentage of clinical center laboratory cost			40.00%
NDA Consulting Corp [Member]
Consulting and advisory fees		$ 4,000	$ 16,000	$ 16,000